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A theoretically informed survey of the views and experiences of practicing 
pharmacists on research conduct, dissemination and translation 
 
Abstract 
Background 
While studies have reported pharmacists’ perspectives of research involvement, almost 
all are limited by sector, have little focus on research translation and have not 
incorporated behaviour change theory.  
Objective 
To determine pharmacists’ views and experiences of research conduct, dissemination 
and translation 
Methods 
This was an electronic cross-sectional survey of pharmacists across six Scottish health 
board areas. Survey items were: demographics; research activities (e.g. conduct, 
dissemination) in the last two years; research interests, experience and confidence in 
research tasks (e.g. proposal writing, data collection); and Likert statements on research 
conduct and dissemination, and translating research findings to practice. 
Conduct/dissemination and translation items were based on the Theoretical Domains 
Framework (TDF). Data were analysed using descriptive and inferential statistics, and 
principal component analysis (PCA) of TDF items. Following determination of internal 
consistency, scores for each component were calculated.   
Results 
The response rate was 19.4% (136/701), with 17 (12.5%) currently involved in 
research. Responses were more positive for interest in research than experience or 
confidence. PCA of research conduct/dissemination items identified three internally 
reliable components of support/opportunities, motivation/outcomes, and 
roles/characteristics. Component scores for support/opportunities to participate in 
research were most negative. PCA of translation items identified three internally reliable 
components of current practices/abilities, consequences and support. Scores for all three 
components were positive, being most positive for consequences of research translation. 
Those in secondary care, with a postgraduate qualification and prescribers scored higher 
for interest, experience, confidence, and for most components (p<0.05).  
 
 
 
Conclusion 
A minority of pharmacists are involved in the research conduct/dissemination and these 
are more likely to be highly qualified individuals based in secondary care. Given the need 
to develop and evaluate new models of pharmaceutical care, involvement should be 
extended to all practice settings. Study findings could be used to develop behaviour 
change interventions targeting individuals and organizations.   
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A theoretically informed survey of the views and experiences of practicing 
pharmacists on research conduct, dissemination and translation 
Introduction 
The Sicily Statement defining evidence-based practice (EBP) describes five key steps of: 
translation of uncertainty to an answerable question; systematic retrieval of best 
evidence; critical appraisal for validity, clinical relevance and applicability; application; 
and performance evaluation.1 EBP is therefore dependent on the conduct and 
dissemination of research, and translation to practice. While it is unreasonable to expect 
all practising pharmacists to be involved in research conduct or dissemination, more may 
require to translate research findings (e.g. changes in the pharmacotherapy evidence 
base for acute and chronic conditions) to their practice. The relevance of research to 
pharmacy practice is well-recognized at national and international levels, being 
emphasized in policy and practice statements of key pharmacy organizations (Table 1).  
 < Insert Table 1 here> 
Research capacity, defined as ‘enhancing the abilities of individuals, organizations and 
systems to undertake and disseminate high quality research effectively and 
efficiently.’Given the emphasis on research in pharmacy policy and practice statements 
and that capacity relates to the development of individuals and organizations, further 
consideration of capacity building is warranted.7 A systematic review of the peer 
reviewed literature (1990-2014) synthesised pharmacists’ views and attitudes around 
involvement in practice research, and associated barriers and facilitators.8 The key 
findings were that while participants recognized the value of practice based research, 
factors such as time, research training and support were key limitations to their 
involvement. Since 2014, a number of similar studies have explored views and attitudes 
of pharmacists towards practice research, with generally similar findings.9-17 Whilst 
acknowledging this accumulation of evidence, there are several key weaknesses to these 
studies. Almost all have focused on aspects of research conduct in one practice setting, 
and only one survey from Malaysia reporting data on research translation, with higher 
educational level linked to higher translation.18  
One further key limitation of the evidence base derived from these studies is the 
omission of inclusion of comprehensive behavior change theories (i.e. those which 
explain why behaviour changes or not) within the stages of research design, data 
collection, analysis and interpretation. Considering theory in research processes 
enhances robustness and rigour, and the relevance and impact of the findings.19 
Incorporation of behavior change theory also permits the identification of possible 
theoretical mechanisms of behavior change leading to the development of targeted 
 
 
intervention(s).20 It is claimed that these interventions are more likely to be effective in 
altering behavior compared to more pragmatic approaches.21  
In Scotland in 2017 the Chief Pharmaceutical Officer of the Scottish Government 
launched a refreshed strategy for the profession, ‘Achieving Excellence in Pharmaceutical 
Care’.22 The two key priorities are  
i. improving pharmaceutical care, thus delivering safer use of medicines for the 
people of Scotland 
ii. enabling pharmaceutical care transformation by ensuring capability and capacity 
by further developing the pharmacy workforce, developing a digitally enabled 
infrastructure, and planning and delivery requirements for sustainable 
pharmaceutical care services.  
The need for services to be systematically developed, implemented and evaluated is 
articulated throughout the strategy, including the need to involve practicing pharmacists 
in both research conduct and translation of findings. The tasks involved in such service 
advances are likely to be resource intensive, particularly when undertaken at scale in an 
organization or across organizations. Robust, rigorous pharmacy practice research 
should therefore be a key focus for all stages of developing new services and 
interventions, implementing to practice settings and evaluating to ensure that desired 
outcomes (clinical, humanistic and economic) are achieved. With only one qualitative 
study of pharmacists’ perceptions of pharmacist-led research in one geographical area of 
Scotland9, there is a need to apply behavior change theory to study the involvement of 
practicing pharmacists in Scotland in the conduct, dissemination and translation of 
research findings.  
The aim of this study was to determine pharmacists’ views and experiences of research 
conduct, dissemination and translation.  
 
 
 
Method  
Design 
The design was a cross-sectional survey using an online questionnaire.   
Setting 
The study took place from May to November 2017 across the six most northern, remote 
and rural health board areas in Scotland accounting for around 30% of pharmacists in 
Scotland.   
Questionnaire development and testing 
The draft questionnaire was based on one previously used by members of the research 
team,10 with contextualisation for practice in Scotland and the addition of items derived 
from behaviour change theory. The draft questionnaire was reviewed for face and 
content validity by several academics, researchers and practicing pharmacists. Items 
were in domains of: demographics (12 items); research activities in the last two years (4 
items); research interests, experience and confidence (48 items); research conduct and 
dissemination (33 items); translating research (21 items); readiness to participate in 
research (1 item); research training (2 items); and research plans and areas of interest 
(2 items). Question types were a combination of closed, 5-point Likert scales and open 
to allow detailed comment. Items were based on several theoretical frameworks. Those 
on conduct, dissemination, and translation were based on the Theoretical Domains 
Framework (TDF) which includes constructs from 33 behavior change theories.23 The 
domains  (i.e. the determinants of behaviour) are: knowledge; skills; social/professional 
role and identity; beliefs about capabilities; optimism; beliefs about consequences; 
reinforcement; intentions; goals; memory, attention and decision processes; 
environmental context and resources; social influences; emotions; and behavioral 
regulation. The Determinants of Implementation Behavior Questionnaire, which 
incorporates the TDF domains, was used as a basis for the development of the individual 
items.24 Readiness to participate in research was categorised according to the Stage of 
Change model of ‘precontemplation’, ‘contemplation’, ‘preparation’ and ‘action’.25 In the 
demographics section, respondents classified themselves as innovators, early adopters, 
early majority, late majority and laggards based on receptivity to change, using the item 
wording as described by Rogers.26 Given the previous use of a similar questionnaire,10 no 
pilot stage was conducted. The questionnaire was developed in SurveyMonkey© and 
tested for compatibility with platforms (PC, tablet, smartphone), browsers and NHS 
email and internet filters. 
 
 
 
Recruitment and data collection 
An email was sent, by either the health board Director of Pharmacy or the lead research 
pharmacist, to all pharmacists registered with the General Pharmaceutical Council 
practicing in any primary or secondary care setting. The email contained a link to the 
participant information leaflet and the questionnaire. Evidence based strategies were 
employed to maximise the response rate,27 including providing: an information leaflet 
outlining the study aim, potential benefits and assured anonymity; a visually attractive 
questionnaire; and two follow-up email reminders.  
Analysis  
Descriptive analysis was undertaken for: demographics; research activities; research 
interest, experience and confidence; views on research conduct, dissemination and 
translation; and readiness to participate in research and research training. Internal 
consistencies of responses on interest, experience and confidence were tested using 
Cronbach’s alpha, aiming for values ≥0.7.28 Total scores (median and interquartile range 
(IQR)) for each scale were obtained by assigning values (1=no to 5=very). Differences 
in total scores of interest, experience and confidence were tested using Friedman’s two 
way analysis of variance by ranks. Correlation between overall scores of 
interest/experience, interest/confidence and experience/confidence were assessed using 
Spearman’s rho. Relationships between demographic variables and scores were tested 
using Mann-Whitney U test (2 groups) and Kruskall-Wallis (>2 groups). P-values ≤0.05 
were considered to be statistically significant.  
Items measured relating to views on research conduct, dissemination and translation 
were subjected to principal components analysis (PCA) to reduce the large number of 
items to a smaller number of components.29 Orthogonal (Varimax) rotation was 
performed initially to aid in the interpretation of the components, and the results were 
compared to oblique (Promax) rotation. The number of components retained was based 
on the Kaiser criterion (Eigenvalues >1), visual inspection of the scree plot and 
meaningfulness of the results according to the theoretical framework. The analysis 
included items that were not freestanding, cross-loading or decreasing the scale’s 
internal reliability, and that displayed acceptable communalities, with factor 
pattern/structure coefficients above 0.4. In performing PCA, the Kaiser-Meyer-Olkin 
(KMO) measure of sampling adequacy and the Bartlett’s Test of Sphericity were used to 
assess the suitability of the sample for PCA.29 Following determination of internal 
consistencies, total scores (median and interquartile range, IQR) were obtained by 
assigning scores of 1 (strongly disagree) to 5 (strongly agree) to each of the Likert 
statement responses and each compared to the scale midpoint. Inferential analysis 
 
 
(Mann-Whitney U, Kruskal-Wallis) was used to explore any relationship between 
demographic variables and component scores.  
Research readiness and research training were both summarised in two categories: 
those ‘not ready’ (I have never thought about being involved in research/ I have thought 
about being involved in research but have taken no action, and I have never thought 
about research training / I have thought about research training but have taken no 
action) and the remainder, ‘ready’. Variables significantly associated with readiness were 
identified using Chi-square.  
Content analysis was independently performed by two members of the research team on 
the responses to the open questions, looking for patterns, similarities and differences.30  
Ethical approval 
The study was approved by a university ethics review committee and was considered 
exempt from NHS ethical review. Management approval was obtained from the Research 
and Development committees of each of the six participating health boards 
(NRS17/219303). Return of the questionnaire was deemed an indication of consent to 
participate.   
 
 
Results  
Response rates 
Of the 172 responses, 36 had completed only the demographics section and were 
removed from any further analysis, giving a response rate of 19.4% (136/701). 
Responses rates across each of the health boards varied from 15.1% (40/265) to 50.0% 
(6/12).  
Personal and practice demographics 
Respondent demographics are given in Table 2. Most were female (76.5%, n=104), with 
two thirds aged <45 years (66.2%, n=90) with <20 years’ experience as pharmacists 
(64.7%, n=88). Around half were working full-time (57.6%, n=92), had a postgraduate 
qualification (58.1%, n=79) and were registered prescribers (50.7%, n=69). Secondary 
care was the most common sector of practice (41.2%, n=56). In terms of receptivity to 
change, more than half (58.8%, n=80) classified themselves as innovators and early 
adopters, and none as laggards.   
  <Insert Table 2 here> 
Research involvement 
Over the preceding two years, 54 (39.7%) had participated in research, 31 (22.8%) had 
conducted research, 16 (11.8%) had presented research at a national or international 
conference and 11 (8.1%) had published research in a peer-reviewed journal.  
Research interest, experience and confidence 
Responses to items on interest, experience and confidence are given in Table 3.  
  <Insert Table 3 here> 
The Cronbach’s alpha internal consistencies of the three scales of interest, experience 
and confidence were all 0.96, 0.96 and 0.97 respectively indicating high internal 
reliability. The median summary score (range possible 16-80, scale mid-point 48; high 
scores positive) for research interest was 50 (IQR 41.25-61), research experience 38.5 
(IQR 28-46.25) and research confidence 42 (IQR 32.25-51.75). Summary scores for 
interest were significantly higher than confidence which were significantly higher than 
experience (χ2, p<0.001). There were positive correlations between total scores for 
interest and experience, interest and confidence, and confidence and experience 
(Spearman’s rho, p<0.001) with those more interested also more experienced and 
confident. Moderately high levels of interest were reported for all items other than 
‘writing a research proposal’ (51.5%, n=70 reporting little or no interest). More than two 
thirds had little or no experience of: ‘conducting a systematic review’ (69.1%, n=94); 
 
 
‘using qualitative research methods’ (68.4%, n=93) ‘giving an oral presentation at 
national or international conferences’ (69.1%, n=94); and ‘writing and publishing 
research in academic journals’ (79.5%, n=108).  More than two thirds of the 
respondents had little or no confidence in writing and publishing research in academic 
journals’ (72.1%, n=98).   
Scores of interest were significantly higher (thus more positive) for respondents who had 
been registered as pharmacists for 11-20 years (Kruskal-Wallis, p<0.05), those with a 
postgraduate qualification (Mann-Whitney U, p<0.005) and those who considered 
themselves to be either innovators/early adopters (Mann-Whitney U, p=0.001). Scores 
of experience were similarly significantly higher for those registered as pharmacists for 
11-20 years (Kruskal-Wallis, p<0.005), with a postgraduate qualification (Mann-Whitney 
U, p<0.001), registered prescribers (Mann-Whitney U, p<0.001) and those innovative or 
role models (Mann-Whitney U, p=0.001). For confidence, scores were significantly higher 
for those registered as pharmacists for 11-20 years (Kruskal-Wallis, p<0.005), 
possessing a postgraduate qualification (Mann-Whitney U, p<0.001), registered 
prescribers (Mann-Whitney U, p<0.001) and innovators/early adopters (Mann-Whitney 
U, p<0.005). 
Participation in research 
One hundred and twenty-four respondents completed all items relating to views on 
participation (conduct/dissemination) in research. When these items were subjected to 
PCA, the correlation matrix contained multiple coefficients above 0.3. The Kaiser–Meyer–
Olkin measure of sampling adequacy (0.88) and Bartlett’s test of sphericity (significance 
<0.001) confirmed the factorability of the items. Three components had Eigenvalues 
exceeding 1.0, with the three-factor solution explaining 55.9% of the variance. The three 
components were labelled: support and opportunities to participate in research 
(Cronbach’s alpha internal consistency 0.93); motivation for and outcomes of 
participation in research (Cronbach’s alpha internal consistency 0.89); and individual 
roles and characteristics around participation in research (Cronbach’s alpha internal 
consistency 0.87). Responses to items of these three components are given in Table 4. 
  <Insert Table 4 here> 
Component 1 – Support and opportunities to participate in research 
Respondents generally held neutral views, with a median overall score of 47 (IQR 41-
55), range possible 17-85 (midpoint 51), with 85 representing the highest possible 
positive score. The statement with the highest level of disagreement was ‘I have 
sufficient time to participate in research’ (disagree/strongly disagree n=94, 69.8%). 
Other statements with more than 50% of respondents disagreeing were related to 
 
 
‘working within a research active environment’ (n=63, 50.8%), and being aware of 
research priorities of the organization (n=63, 50.8%), opportunities for research training 
(n=63, 50.8%) and funding (n=69, 55.6%). Component 1 scores were statistically 
significantly higher for innovators/early adopters (Mann-Whitney U, p<0.05). 
Component 2 – Motivation for and outcomes of participation in research 
Responses were generally positive, with a median overall score of 28 (IQR 25-31), range 
possible 7-35 (midpoint 21), with 35 representing the highest possible positive score. 
While almost all felt that participating in research would be of benefit to their profession 
(agree/strongly agree n=117, 94.4%) and patients (agree/strongly agree n=112, 
90.4%), less felt that there would be benefits to their own career (agree/strongly agree 
n=90, 72.6%). Component 2 scores were statistically significantly higher for 
respondents who registered as pharmacists <5 years (Kruskal-Wallis, p<0.05). 
Component 3 – Individual roles and characteristics around participation in research 
Respondents generally held positive views, with a median overall score of 35 (IQR 29-
39), range possible 10-50 (midpoint 30), with 50 representing the highest possible 
positive score.  The most negative score was in relation to research participation already 
being part of their practise (disagree/strongly disagree n=54, 43.6%). Component 3 
scores were statistically significantly higher for those in secondary care (Kruskal-Wallis, 
p<0.01), with a postgraduate qualification (Mann-Whitney U, p<0.001) and 
innovators/early adopters (Mann-Whitney U, p=0.001). 
Readiness to participate in research 
In response to questions on involvement in research, 16.2% (n=22) had never thought 
about being involved in research, 19.1% (n=26) had thought about being involved but 
had taken no action, 10.3% (n=14) had thought about being involved and discussed 
with others, 17.6% (n=24) had been involved in research in the past but had no plans to 
be involved in the future, 14.7% (n=20) had been involved in research in the past and 
had plans to be involved in the future, and 12.5% (n=17) were currently involved in 
research. Those more ready were more likely to be >35 years (χ2, p<0.05), working in 
secondary care (χ2, p<0.001), pharmacists >10 years (χ2, p<0.05), having a 
postgraduate qualification (χ2, p<0.001) and being prescribers (χ2, p=0.001). 
In terms of research training, 28.7% (n=39) had never thought about research training, 
27.9% (n=38) had thought about research training but had taken no action, 10.3% 
(n=14) had thought about research training and discussed with others, 0.7% (n=1) had 
a plan for their research training, 1.5% (n=2) had enrolled for research training and 
21.3% (n=29) had undertaken research training. Those more ready were more likely to 
 
 
be working in secondary care (χ2, p=0.001), having a postgraduate qualification (χ2, 
p<0.05) and being prescribers (χ2, p<0.05).  
Almost three quarters of respondents (70.7%, n=96) expressed interest in being 
involved in some form of research training; almost half (41.9%, n=57) opted for training 
but not leading to a formal qualification, 14.8% (n=20) for university training at 
postgraduate level and 14.0% (n=19) for university training at doctorate level.  
Application of research outcomes to practice 
One hundred and twenty-four respondents completed all attitudinal items on the 
application of research outcomes (translation) to their practice. When these items were 
subjected to PCA, the correlation matrix contained multiple coefficients above 0.3. The 
Kaiser–Meyer–Olkin measure of sampling adequacy (0.90) and Bartlett’s test of 
sphericity (p<0.001) confirmed the factorability of the items. Three components had 
eigenvalues exceeding 1.0, with the three-factor solution explained 61.4% of the 
variance. The three components were labelled: current practices and abilities to apply 
research outcomes (Cronbach’s alpha internal consistency 0.91); consequences of 
applying research outcomes to practice (Cronbach’s alpha internal consistency 0.90); 
and support to apply research outcomes to practice (Cronbach’s alpha internal 
consistency 0.88). Responses to items of these three components are given in Table 5. 
 <Insert table 5 here) 
Component 1 – Current practices and abilities to apply research outcomes 
Respondents generally held positive views, with a median overall score of 40 (IQR 35-
43.75), range possible 11-55 (midpoint 33), with 55 representing the highest possible 
positive score. The statements with the lowest levels of agreement were relating to 
supporting others to apply research outcomes (agree/strongly agree n=58, 46.8%) and 
having clear goals to apply research outcomes (n=46, 37.1%). Component 1 scores 
were statistically significantly higher for respondents who were male (Mann-Whitney U, 
p=0.025), those in secondary care (Kruskal-Wallis, p=0.001), those with postgraduate 
qualifications (Mann-Whitney U, p<0.001), prescribers (Mann-Whitney U, p<0.05) and 
those innovators/early adopters (Mann-Whitney U, p<0.001). 
Component 2 – Consequences of applying research outcomes to practice  
Responses were generally very positive, with a median overall score of 24 (IQR 23-28), 
range possible 6-30 (midpoint 18), with 30 representing the highest possible positive 
score. The statement with the highest level of agreement was that applying research 
outcomes would be of benefit for patients (agree/strongly agree n=116, 93.6%). 
Component 2 scores were statistically significantly higher for those in secondary care 
 
 
(Kruskal-Wallis, p<0.05), pharmacists for 11-20 years (Kruskal-Wallis, p<0.05), and 
innovators/early adopters (Mann-Whitney U, p<0.05). 
Component 3 – Support to apply research outcomes to practice  
Respondents generally held positive attitudes, with a median overall score of 23 (IQR 
20-26), range possible 7-35 (midpoint 21), with 35 representing the highest possible 
positive. The most negative score was in relation to having access to sufficient resources 
(strongly disagree/disagree n=88, 71.0%) and sufficient time (strongly 
disagree/disagree n=77, 62.1%). Component 3 scores were statistically significantly 
higher for those working in secondary care (Kruskal-Wallis, p<0.05).  
 
Content analysis of the textual responses to the open questions identified several key 
themes. While many expressed a desire to be more involved in research generally, lack 
of resources such as staffing, support and time were considered as key barriers, 
“I would be more interested in becoming involved in research and appreciate its 
importance; however, chronic understaffing (due to maternity leave, sickness, 
failure to recruit etc.) means that it is a struggle to stay on top of the daily 
workload. All research would have to be done in own time, and this is a big 
commitment.” 
“I would love to be more involved in research in the fields I work in, I often think 
of ideas I would like to see explored but find it frustrating to find support and 
time to do so in existing role.” 
There was also an expressed need and desire to link academia and practice to better 
define research areas and questions considered more relevant hence more likely to 
inform and impact practice, 
“I would like there to be more links between those in practice and research and 
bridge the gaps…It seems a long time since any joint working like this has taken 
place.” 
“I think those in practice should get more opportunity to shape the direction of 
research as they are often more aware of the gaps and perhaps what is needed.” 
“…often we are asked to participate in research of little value to us and rarely 
hear back on the change the research has made to 
us/patient/organization/profession.” 
 
 
While those involved in research in the past (e.g. MSc research project) acknowledged 
the benefits of publication, this appeared to rarely happen in practice, 
“I completed my MSc research project, however did not have the time to 
publish…I also would have no idea how to go about publishing…it is a skill that I 
struggle with.” 
“I have found it hard to get the momentum to keep anything we have started to 
be complete and often never get round to writing up or submitting for 
publication.” 
 
 
 
Discussion 
Statement of key findings 
While respondents were generally interested in research, they were markedly less 
experienced or confident. PCA of items relating to views on research 
conduct/dissemination, and translation each identified three components. For research 
conduct/dissemination, the three components were: ‘support and opportunities for 
participation’; ‘motivation for and outcomes of participation’; and individual roles and 
characteristics around participation’. While scores for motivation and outcomes, and 
roles and characteristics were positive, those for support and opportunities were more 
negative. For translation, the three components were: ‘current practices and abilities to 
apply research outcomes’; ‘consequences of applying research outcomes’; and ‘support 
to apply research outcomes’. Scores for all three components were positive, being most 
positive for consequences of applying research outcomes. Only one eighth of the 
respondents were currently involved in research. Those in secondary care, with a 
postgraduate qualification, prescribers and innovators/early adopters scored higher for 
interest, experience, confidence, readiness, and for most components.  
Strengths and weaknesses 
Key strengths of this research are the use of a framework of behavior change theories 
(TDF) in the development of selected questionnaire items, the focus on research 
conduct/dissemination and translation, and recruiting from all sectors of pharmacy 
practice. There are, however, several limitations hence the findings should be interpreted 
with caution. Despite all strategies to encourage participation, the response rate was low 
at around 20% which may have introduced response bias with non-respondents having 
no or little interest in research. The validity of self-reported data could not be confirmed 
and there may have been an elements of social desirability bias. Acquiescence bias may 
also have occurred surrounding the use of standard, fixed option responses for each 
item. Furthermore, responses are skewed with a higher proportion of those with 
postgraduate qualifications, prescribers and secondary care practice compared to the 
Scottish pharmacist population. The results may therefore lack generalisability within the 
study areas, Scotland and beyond. However, it is highly likely that the findings will 
resonate widely. 
Interpretation of findings 
Pharmacy practice models are developing at a pace globally,2 and particularly in Scotland 
with developments of government policy on the implementation of pharmacist 
independent prescribing, shared and integrated models of care and pharmacy 
 
 
practitioners practicing within primary care medical practices.22,31 Robust and rigorous 
research to demonstrate effectiveness, cost-effectiveness and safety is warranted and 
must be widely disseminated to achieve the greatest impact on professional practice, 
patient care, the economy and society.32 The argument can be made that pharmacy 
practice research should involve practicing pharmacists in all stages of research design, 
conduct and reporting. Furthermore, pharmacists should be reflecting on the findings of 
key research studies in relation to their practice and be considering adapting their 
practice accordingly.  
The overall scores for research interest, experience and confidence were generally 
neutral, with those for interest being highest. These findings are not unique and have 
been identified in other pharmacist populations,8-18 and other health professions of 
medicine, nursing, social work and speech-language pathology.33-38 While responses to 
‘writing a research proposal’ were particularly negative, this is not surprising given that 
not all pharmacists would be expected to be leading research teams or studies. 
Responses for ‘writing and publishing in academic journals’ were also negative, with 
particular issues around experience and confidence. Notably, few of the respondents had 
published any research in a peer-reviewed journal in the previous two years, a finding 
which was also apparent in the content analysis of textual responses. Given the need for 
dissemination of research to achieve the greatest impact,32 it is vital that research 
findings of all studies, including those with negative results, are published promptly 
following study completion.  
In terms of the PCA of the items on research conduct/dissemination, component scores 
for ‘support and opportunities to participate in research’ were the lowest and generally 
neutral. This component included items on time for research, the environment, research 
priorities, opportunities, access to resources and individual goals for research. 
Interestingly, those respondents considering themselves innovators/early adopters 
scored higher. It may be that these individuals are more likely to set their own goals, 
seek opportunities, support and access. For ‘motivation for and outcomes of participation 
in research’, respondents were in agreement with the potential impact of research on 
patient care, professional practice and their career. In the last component, ‘individual 
roles and characteristics around participation…’ the item with the lowest score was 
around research being part of their practice. If research is not adequately resourced, 
then individuals may feel that it is not prioritised and can only be conducted either as 
part of a qualification or in their own time. This was highlighted in the content analysis of 
the responses to the open questions and also has been identified as a barrier by others. 
8-18 
 
 
While several of these factors have been identified by others as key barriers to research 
participation none of these previous studies incorporated behavior change theory. 
Incorporating theory into research design, conduct and reporting is likely to generate 
findings which are much more comprehensive compared to studies which are conducted 
more pragmatically. Items within this component of ‘support and opportunities to 
participate in research’ can be mapped to TDF, enabling the identification of relevant 
behavior change interventions, ‘coordinated sets of activities designed to change 
specified behavior patterns’. These  consist of interacting components known as 
‘behavior change techniques’ (BCTs), which are ‘observable and replicable components 
designed to change behavior’.39 Evidence based BCTs have been mapped to specific TDF 
domains to facilitate intervention development.39,40 The lowest scoring items within this 
component map to TDF domains of knowledge (e.g. organization research priorities, 
training and funding opportunities), and ‘environmental context and resources’ (e.g. 
research active environment, time, support). While BCTs for knowledge are targeted at 
the individual, those relating to environmental context and resources relate more to 
organizational culture and will require intervention at the levels of the organization, 
leadership and management.41 
Mapping the responses of research readiness to the Stage of Change model,25 almost 
one fifth of respondents were at the ‘precontemplation’ stage, never having thought 
about participation, and only one eighth currently participating, ‘active’. For research 
training, the results were more marked with over a quarter being ‘precontemplation’. 
Interestingly, those in secondary care, with a postgraduate qualification and being 
prescribers were more ready for research and research training. It may be that this 
setting is more conducive to research participation (e.g. access to resources, mentors 
etc.) and notably the scores for research interest, experience and confidence were also 
significantly higher for those who had completed postgraduate training.   
PCA components of research translation were different to those for 
conduct/dissemination, with items clustering in ‘current practices and abilities’, 
‘consequences’ and ‘support’. Responses to all items were generally positive and thus 
component scores high, particularly those around consequences to patient care and 
professional practice. However, there were individuals scoring below the midpoint of 
each component hence may require further intervention to ensure that patients are 
receiving the most up-to-date, evidence based care. Given that component scores for all 
three components were significantly higher for those in secondary care, there may be 
merit in studying those in primary care settings in greater depth. 
Many frameworks of research capacity building in healthcare have been published. One 
such framework has principles of: developing skills and confidence through training and 
 
 
opportunities to apply skills; supporting research ‘close to practice’; need for 
partnership/collaboration; dissemination to maximise impact; continuity and 
sustainability; and appropriate infrastructures.42 This study has systematically studied 
pharmacists’ aspirations, interests, experience, confidence, and views on research hence 
the findings can assist organizations to reflect on their strategic aims and plans and 
importantly ensure a positive research culture. Ideally this should be conducted within 
multidisciplinary teams and in partnership with academia.  
While all pharmacists need to be research aware and translate research, fewer are likely 
to be involved in stages of conception, design, conduct and dissemination. The results of 
this study indicate that those in secondary care, with a postgraduate qualification, 
prescribers, and innovators/early adopters are more likely to be interested, experienced 
and confident, motivated with adequate support, more ready and should perhaps be 
targeted. However, the aspirations of the individual must also be considered in terms of 
their professional development. For those aspiring to be research leaders, frameworks 
which integrate academic and research pursuits integrated with clinical practice (i.e. 
‘clinical academics’) may be suitable career pathway. While these are well-recognized 
within medicine and dentistry, and to a lesser extent, within nursing, they are less well-
established for pharmacy. However, a recent paper from NHS Health Education England, 
has suggested a pathway for health professions outside of medicine and dentistry.43 
Further work 
Further research should focus on the development and testing of interventions around 
research capacity building (at individual and organizational levels) with outcome 
measures of process (e.g. research funding applications, research training events, 
research studies) and outcomes (e.g. conference presentations, publications) and impact 
(e.g. on patient care, professional practice). 
 
Conclusion 
Pharmacists are generally positive around the translation of research findings to practice, 
particularly around the consequences for patient care and professional practice. A 
minority of pharmacists are involved in the conduct and dissemination of research and 
these are more likely to be based in secondary care with a postgraduate qualification, 
being prescribers and innovators/early adopters. Given the need to develop, implement 
and evaluate new models of pharmaceutical care, involvement should be extended to all 
practice settings. This may require behaviour change interventions targeted at both the 
individuals and the organizations.  
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Tables 
Table 1. Policy and practice statements, with emphasis on practice research, of key 
pharmacy organizations 
Organization Statements  
International 
Pharmaceutical 
Federation (FIP)2 
 
Vision 
Wherever and whenever decision-makers discuss any aspects 
of medicines on a global level, FIP is at the table. 
 
Mission 
Improve global health by advancing pharmaceutical education, 
pharmaceutical sciences and pharmaceutical practice thus 
encouraging, promoting and enabling better discovery, 
development, access to and responsible use of appropriate, 
cost-effective, quality medicines worldwide. 
 
…such a vision involves and evokes a wide range of responses 
and commitments:…identifying and taking on significant 
responsibilities in pharmacy practice research 
 
European Society of 
Clinical Pharmacy 
(ESCP)3 
 
Vision 
ESCP is an international leader in advancing quality and 
innovation in clinical pharmacy education, practice and 
research. 
 
Mission 
ESCP is an organization that promotes, supports, implements 
and advances education, practice and research in clinical 
pharmacy in order to optimise outcomes for patients and 
society. 
 
ESCP advances research by: 
1. Disseminating clinical pharmacy research findings 
2. Stimulating innovative and high quality research in all areas 
of clinical pharmacy 
3. Promoting and enabling multicentre research in all areas of 
clinical pharmacy both within countries and between countries 
or differing healthcare delivery systems 
 
European 
Association of 
Hospital Pharmacists 
(EAHP)4 
 
Mission 
EAHP represents and develops the hospital pharmacy 
profession within Europe in order to ensure the continuous 
improvement of care and outcomes for patients in the hospital 
setting. This is achieved through science, research, education, 
practice, as well as sharing best-practice and responsibility 
with other healthcare professionals. 
 
European Statements of Hospital Pharmacy 
Section 6: Education and Research 
 
Statement 6.4. Hospital pharmacists should actively engage in 
and publish research, particularly on hospital pharmacy 
practice. Research methods should be part of undergraduate 
and postgraduate training programmes for hospital 
pharmacists. Hospital pharmacists should be actively involved 
in clinical trials of medicines. 
 
 
 
American Society of 
Health-System 
Pharmacists (ASHP)5 
 
Vision 
Patient outcomes improve because of the leadership and 
clinical skills of pharmacists, as vital members of the 
healthcare team, accountable for safe and effective medication 
use. 
 
Mission 
…to improve the health and well-being of patients through 
appropriate, safe and effective medication use.  
 
(Relating to research) We will accomplish this by: 
• sponsoring high-impact practice research leading to advances 
in patient outcomes 
• providing funding and programs that optimize the 
medication-use system and advance the direct and accountable 
patient care role of pharmacists 
• encouraging innovation and adoption of best practices and 
new patient safety and quality initiatives 
• providing recognition and support to diffuse best practices in 
research, education and practice 
 
Royal 
Pharmaceutical 
Society (RPS)6 
 
Mission 
To promote and represent the professional 
interests of our members, supporting the profession to achieve 
our shared vision for the future. We are committed to 
supporting and empowering our members to make a real 
difference to improving health outcomes for patients. 
 
Professional Standards for Hospital Pharmacy Services 
Standard 6.4d. The pharmacy team leads, actively participates 
in and publishes research… and seeks opportunities to work 
with academia and other research partners 
 
 
  
 
 
Table 2. Personal and practice demographics of respondents (n=136) 
Demographic % (n) 
Age (years) 
   ≤35 
   36-45 
   >45 
   missing 
 
35.3 (48) 
30.9 (42) 
30.9 (42) 
2.9 (4) 
Gender  
   Female 
   Male 
 
76.5 (104) 
23.5 (32) 
Main practice setting 
   Primary care 
   Secondary care  
   Community pharmacy 
   Other 
 
25.0 (34) 
41.2 (56) 
25.7 (35) 
8.1 (11) 
Years of practise as pharmacist 
   ≤10 
   11-20 
  >20 
 
30.1 (41) 
34.6 (47) 
35.3 (48) 
Working schedule 
   Full time 
   Part time 
   As a locum 
   Other 
 
67.6 (92) 
28.7 (39) 
2.2 (3) 
1.5 (2) 
Postgraduate qualifications 
   Yes 
    
 
58.1 (79) 
 
Pharmacist prescriber 
   Yes 
    
 
50.7 (69) 
 
Receptivity to change 
   Innovative with new ways of working (innovator) 
   Serve as a role model for others in relation to new ways of working (early 
adopter) 
   Think for some time before adopting new ways of working (early majority) 
   Cautious in relation to new ways of working; tend to change once most          
peers have done so (late majority) 
   Resist new ways of working (laggard) 
 
35.3 (48) 
23.5 (32) 
38.2 (52) 
 
2.9 (4) 
0 (0) 
 
 
 
Table 3. Responses to items of interest, experience and confidence in specific aspects of research (n=136) 
 Interest % (n) Experience % (n) Confidence % (n) 
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Research advances 
within my field and 
in related areas 
0.7 
(1) 
5.1 
(7) 
19.1 
(26) 
30.9 
(42) 
44.1 
(60) 
24.3 
(33) 
25.7 
(35) 
28.7 
(39) 
16.2 
(22) 
5.1 
(7) 
17.6 
(24) 
22.8 
(31) 
25.7 
(35) 
30.1 
(41) 
3.7 
(5) 
Generating research 
ideas 
4.4 
(6) 
22.8 
(31) 
29.4 
(40) 
26.5 
(36) 
16.9 
(23) 
27.9 
(38) 
35.3 
(48) 
26.5 
(36) 
7.4 
(10) 
2.9 
(4) 
23.5 
(32) 
28.7 
(39) 
29.4 
(40) 
16.2 
(22) 
2.2 
(3) 
Developing research 
questions, aims, 
hypotheses and 
objectives 
8.8 
(12) 
30.1 
(41) 
28.7 
(39) 
19.1 
(26) 
13.2 
(18) 
25.7 
(35) 
39.7 
(54) 
23.5 
(32) 
8.8 
(12) 
2.2 
(3) 
24.3 
(33) 
33.8 
(46) 
25.0 
(34) 
14.7 
(20) 
2.2 
(3) 
Finding relevant 
literature 
6.6 
(9) 
16.9 
(23) 
26.5 
(36) 
29.4 
(40) 
20.6 
(28) 
16.9 
(23) 
18.4 
(25) 
32.4 
(44) 
23.5 
(32) 
8.8 
(12) 
14.0 
(19) 
16.9 
(23) 
31.6 
(43) 
27.2 
(37) 
10.3 
(14) 
 
 
Reviewing literature 7.4 
(10) 
19.1 
(26) 
29.4 
(40) 
26.5 
(36) 
17.6 
(24) 
17.6 
(24) 
19.9 
(27) 
29.4 
(40) 
22.8 
(31) 
10.3 
(14) 
13.2 
(18) 
20.6 
(28) 
30.1 
(41) 
27.2 
(37) 
8.8 
(12) 
Writing a research 
proposal 
14.7 
(20) 
36.8 
(50) 
27.2 
(37) 
13.2 
(18) 
8.1 
(11) 
34.6 
(47) 
31.6 
(43) 
22.8 
(31) 
8.8 
(12) 
2.2 
(3) 
30.1 
(41) 
32.4 
(44) 
23.5 
(32) 
11.8 
(16) 
2.2 
(3) 
Conducting a 
systematic review 
14.0 
(19) 
35.3 
(48) 
27.2 
(37) 
14.7 
(20) 
8.8 
(12) 
39.0 
(53) 
30.1 
(41) 
19.9 
(27) 
8.1 
(11) 
2.9 
(4) 
33.8 
(46) 
32.4 
(44) 
17.6 
(24) 
13.2 
(18) 
2.9 
(4) 
Using quantitative 
research methods 
(e.g. RCTs, cohort 
studies, surveys, 
questionnaires) 
10.3 
(14) 
22.1 
(30) 
36.0 
(49) 
16.9 
(23) 
14.7 
(20) 
30.1 
(41) 
33.8 
(46) 
25.0 
(34) 
7.4 
(10) 
3.7 
(5) 
23.5 
(32) 
27.2 
(37) 
32.4 
(44) 
14.0 
(19) 
2.9 
(4) 
Using qualitative 
research methods 
(e.g. focus groups, 
interviews) 
8.8 
(12) 
25.0 
(34) 
33.8 
(46) 
22.8 
(31) 
9.6 
(13) 
36.0 
(49) 
32.4 
(44) 
19.1 
(26) 
8.8 
(12) 
3.7 
(5) 
24.3 
(33) 
35.3 
(48) 
25.0 
(34) 
12.5 
(17) 
2.9 
(4) 
Analysing and 
interpreting 
quantitative results 
8.8 
(12) 
25.0 
(34) 
28.7 
(39) 
22.8 
(31) 
14.7 
(20) 
24.3 
(33) 
27.9 
(38) 
30.9 
(42) 
14.0 
(19) 
2.9 
(4) 
16.9 
(23) 
33.8 
(46) 
27.2 
(37) 
19.1 
(26) 
2.9 
(4) 
Analysing and 
interpreting 
qualitative results 
9.6 
(13) 
23.5 
(32) 
33.1 
(45) 
22.1 
(30) 
11.8 
(16) 
29.4 
(40) 
31.6 
(43) 
25.0 
(34) 
11.8 
(16) 
2.2 
(3) 
21.3 
(29) 
36.0 
(49) 
24.3 
(33) 
15.4 
(21) 
2.9 
(4) 
Giving an oral 
presentation locally 
9.6 
(13) 
19.1 
(26) 
25.7 
(35) 
27.9 
(38) 
17.6 
(24) 
16.2 
(22) 
18.4 
(25) 
22.1 
(30) 
29.4 
(40) 
14.0 
(19) 
10.3 
(14) 
16.2 
(22) 
29.4 
(40) 
29.4 
(40) 
14.7 
(20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Giving an oral 
presentation at 
national  or 
international 
conference 
14.7 
(20) 
20.6 
(28) 
25.7 
(35) 
24.3 
(33) 
14.7 
(20) 
50.7 
(69) 
18.4 
(25) 
17.6 
(24) 
10.3 
(14) 
2.9 
(4) 
23.5 
(32) 
27.2 
(37) 
23.5 
(32) 
20.6 
(28) 
5.1 
(7) 
Writing and 
publishing research 
in academic journals 
14.0 
(19) 
28.7 
(39) 
26.5 
(36) 
14.0 
(19) 
16.9 
(23) 
59.6 
(81) 
19.9 
(27) 
15.4 
(21) 
2.9 
(4) 
2.2 
(3) 
34.6 
(47) 
37.5 
(51) 
15.4 
(21) 
10.3 
(14) 
2.2 
(3) 
Reading and 
interpreting research 
8.8 
(12) 
17.6 
(24) 
27.2 
(37) 
25.0 
(34) 
21.3 
(29) 
22.8 
(31) 
21.3 
(29) 
24.3 
(33) 
20.6 
(28) 
11.0 
(15) 
14.7 
(20) 
22.1 
(30) 
27.2 
(37) 
30.1 
(41) 
5.9 
(8) 
Applying the 
outcomes of 
research to your 
practice 
3.7 
(5) 
5.9 
(8) 
18.4 
(25) 
28.7 
(39) 
43.4 
(59) 
17.6 
(24) 
14.0 
(19) 
34.6 
(47) 
22.1 
(30) 
11.8 
(16) 
13.2 
(18) 
14.0 
(19) 
28.7 
(39) 
35.3 
(48) 
8.8 
(12) 
Scale statistics, sum 
of allocating 1 (no 
interest, experience, 
confidence) to 5 
(very interested, 
experienced, 
confident) 
Cronbach’s alpha 0.96 
Range possible 16-80 
Mid-point 48 
Median 50 
IQR 41.25-61 
Cronbach’s alpha 0.96 
Range possible 16-80 
Mid-point 48 
Median 38.5 
IQR 28-46.75 
Cronbach’s alpha 0.97 
Range possible 16-80 
Mid-point 48 
Median 42 
IQR 32.25-51.75 
 
 
Table 4. Responses to attitudinal items on aspects of research conduct (n=124)  
Statement Strongly 
agree 
% (n) 
Agree% 
(n) 
Unsure% 
(n) 
Disagree
% (n) 
Strongly 
disagree
% (n) 
Component 1 – Support and opportunities to participate in research 
I work within a research-supportive environment 2.4 (3) 23.4 (29) 34.7 (43) 29.8 (37) 9.7 (12) 
I am aware of the support available for research 2.4 (3) 19.4 (24) 28.2 (35) 37.1 (46) 12.9 (16) 
I am aware of the research priorities for my organization 2.4 (3) 14.5 (18) 31.5 (39) 36.3 (45) 15.3 (19) 
I work within a research-active environment 3.2 (4) 17.7 (22) 28.2 (35) 37.9 (47) 12.9 (16) 
Participating in research is supported by my organization 7.3 (9) 38.7 (48) 37.1 (46) 12.1 (15) 4.8 (6) 
There are opportunities for me to attend research talks and seminars 4.8 (6) 25.0 (31) 19.4 (24) 30.6 (38) 20.2 (25) 
Participation in research is supported by my peers 7.3 (9) 32.3 (40) 37.1 (46) 20.2 (25) 3.2 (4) 
I am aware of training opportunities relating to research 4.8 (6) 17.7 (22) 26.6 (33) 37.9 (47) 12.9 (16) 
I am aware of funding opportunities relating to research 2.4 (3) 12.9 (16) 29.0 (36) 38.7 (48) 16.9 (21) 
I am aware of opportunities to participate in research 4.8 (6) 23.4 (29) 27.4 (34) 29.8 (37) 14.5 (18) 
Participating in research is supported by my line manager 12.1 (15) 37.1 (46) 39.5 (49) 7.3 (9) 4.0 (5) 
I have sufficient time to participate in research  1.6 (2) 6.5 (8) 16.1 (20) 46.0 (57) 29.8 (37) 
There are opportunities for me to attend national and international 
research conferences 
2.4 (3) 27.4 (34) 18.5 (23) 26.6 (33) 25.0 (31) 
I already have access to all of the resources I need to participate in 
research 
2.4 (3) 8.9 (11) 39.5 (49) 37.9 (47) 11.3 (14) 
I have clear goals for participating in research 8.1 (10) 16.9 (21) 32.3 (40) 30.6 (38) 12.1 (15) 
Other pharmacists I know participate in research 11.3 (14) 43.5 (54) 22.6 (28) 19.4 (24) 3.2 (4) 
Other health professionals participate in research 21.0 (26) 54.8 (68) 18.5 (23) 4.8 (6) 0.8 (1) 
Component statistics, sum of allocating 1 (strongly disagree) to 5 (strongly agree)  
Cronbach’s alpha 0.93 
Range possible 17-85, with 85 representing best positive attitudinal score 
Mid-point 51 
Median 47 
IQR 41-55 
Component 2 – Motivation for and outcomes of participation in research  
Participating in research will be of benefit to my profession 34.7 (43) 59.7 (74) 5.6 (7) 0 0 
Participating in research will be of benefit to my career 27.4 (34) 45.2 (56) 15.3 (19) 12.1 (15) 0 
Participating in research will be of benefit to patients 33.9 (42) 56.5 (70) 8.9 (11) 0.8 (1) 0 
Participating in research will be of benefit to my organization 26.6 (33) 58.9 (73) 12.9 (16) 1.6 (2) 0 
Participating in research will be of benefit to me 24.2 (30) 56.5 (70) 14.5 (18) 4.0 (5) 0.8 (1) 
I get/would get professional satisfaction from participating in research 27.4 (34) 53.2 (66) 13.7 (17) 4.0 (5) 1.6 (2) 
I am motivated to participate in research 12.9 (16) 39.5 (49) 26.6 (33) 16.1 (20) 4.8 (6) 
 
 
Component statistics, sum of allocating 1 (strongly disagree) to 5 (strongly agree)  
Cronbach’s alpha 0.89 
Range possible 7-35, with 35 representing best positive attitudinal score 
Mid-point 21 
Median 28 
IQR 25-31 
Component 3 – Individual roles and characteristics around participation in research 
*I feel/would feel anxious about participating in research 8.1 (10) 22.6 (28) 21.8 (27) 37.9 (47) 9.7 (12) 
*Only academics should participate in research 0.8 (1) 0.8 (1) 7.3 (9) 55.6 (69) 35.5 (44) 
I am confident in my ability to participate in research 11.3 (14) 41.1 (51) 22.6 (28) 21.0 (26) 4.0 (5) 
I am sufficiently skilled to participate in research 6.5 (8) 43.5 (54) 35.5 (44) 11.3 (14) 3.2 (4) 
I have sufficient knowledge to participate in research 10.5 (13) 41.9 (52) 33.9 (42) 11.3 (14) 2.4 (3) 
I am competent to participate in research 10.5 (13) 46.8 (58) 31.5 (39) 8.9 (11) 2.4 (3) 
I am able to determine my own research-related training needs 5.6 (7) 36.3 (45) 39.5 (49) 13.7 (17) 4.8 (6) 
Participating in research is already part of my practice 5.6 (7) 33.1 (41) 17.7 (22) 35.5 (44) 8.1 (10) 
It is part of my role to participate in research 15.3 (19) 50.0 (62) 19.4 (24) 7.3 (9) 8.1 (10) 
I support others to participate in research 11.3 (14) 41.1 (51) 18.5 (23) 23.4 (29) 7 (5.6) 
*negative statement, reverse scored 
Component statistics, sum of allocating 1 (strongly disagree) to 5 (strongly agree)  
Cronbach’s alpha 0.87 
Range possible 10-50, with 50 representing best positive attitudinal score 
Mid-point 30 
Median 35 
IQR 29-39 
 
  
 
 
Table 5. Responses to attitudinal items on aspects of applying research outcomes to practice (n=124)  
Statement Strongly 
agree 
% (n) 
Agree 
% (n) 
Unsure 
% (n) 
Disagree
% (n) 
Strongly 
disagree 
% (n) 
Component 1 – Current practices and abilities to apply research outcomes 
I am confident in my ability to interpret and apply relevant research 
outcomes to my practice 
11.3 (14) 41.9 (52) 23.4 (29) 19.4 (24) 4.0 (5) 
I am competent in my ability to interpret and apply relevant research 
outcomes to my practice 
11.3 (14) 51.6 (64) 22.6 (28) 12.9 (16) 1.6 (2) 
I have sufficient knowledge to interpret and apply relevant research 
outcomes to my practice 
10.5 (13) 59.7 (74) 16.9 (21) 11.3 (14) 1.6 (2) 
I am sufficiently skilled to interpret and apply relevant research 
outcomes to my practice 
9.7 (12) 51.6 (64) 29.0 (36) 6.5 (8) 3.2 (4) 
* I feel/would feel anxious about interpreting and applying relevant 
research outcomes to my practice 
7.3 (9) 16.9 (21) 21.8 (27) 44.4 (55) 9.7 (12) 
I already interpret and apply relevant research outcomes to my 
practice 
12.9 (16) 50.8 (63) 15.3 (19) 15.3 (19) 5.6 (7) 
It is part of my role to interpret and apply relevant research outcomes 
to my practice 
29.0 (36) 53.2 (66) 5.6 (7) 6.5 (8) 5.6 (7) 
I support others to interpret and apply relevant research outcomes to 
their practice 
9.7 (12) 37.1 (46) 25.8 (32) 20.2 (25) 7.3 (9) 
I have clear goals for interpreting and applying relevant research 
outcomes to my practice 
8.9 (11) 28.2 (35) 30.6 (38) 21.8 (27) 10.5 (13) 
* Only leaders of the profession should interpret and apply relevant 
research outcomes to practice 
0.8 (1) 1.6 (2) 7.3 (9) 60.5 (75) 29.8 (37) 
I am motivated to interpret and apply relevant research outcomes to 
my practice 
16.1 (20) 49.2 (61) 19.4 (24) 11.3 (14) 4.0 (5) 
* negative statement, reverse scored 
Component statistics, sum of allocating 1 (strongly disagree) to 5 (strongly agree)  
Cronbach’s alpha 0.91 
Range possible 11-55, with 55 representing best positive attitudinal score 
Mid-point 33 
Median 40 
IQR 35-43.75 
Component 2 – Consequences of applying research outcomes to practice 
Interpreting and applying relevant research outcomes to my practice 
will be of benefit to my career 
22.6 (28) 54.0 (67) 12.9 (16) 10.5 (13) 0 
Interpreting and applying relevant research outcomes to my practice 
will be of benefit to me 
28.2 (35) 59.7 (74) 9.7 (12) 2.4 (3) 0 
 
 
Interpreting and applying relevant research outcomes to my practice 
will be of benefit to my organization 
29.8 (37) 58.9 (73) 9.7 (12) 1.6 (2) 0 
Interpreting and applying relevant research outcomes to my practice 
will be of benefit to my profession 
37.9 (47) 53.2 (66) 8.9 (11) 0 0 
Interpreting and applying relevant research outcomes to my practice 
will be of benefit to patients 
33.9 (42) 59.7 (74) 6.5 (8) 0 0 
I get/would get professional satisfaction from interpreting and 
applying relevant research outcomes to my practice 
25.8 (32) 58.1 (72) 12.1 (15) 3.2 (4) 0.8 (1) 
Component statistics, sum of allocating 1 (strongly disagree) to 5 (strongly agree)  
Cronbach’s alpha 0.90 
Range possible 6-30, with 30 representing best positive attitudinal score 
Mid-point 18 
Median 24 
IQR 23-28 
Component 3 – Support to apply research outcomes to practice 
Interpreting and applying relevant research outcomes to my practice 
is supported by my organization 
9.7 (12) 46.0 (57) 29.8 (37) 10.5 (13) 4.0 (5) 
Interpreting and applying relevant research outcomes to my practice 
is supported by my peers 
8.9 (11) 44.4 (55) 33.1 (41) 11.3 (14) 2.4 (3) 
Interpreting and applying relevant research outcomes to my practice 
is supported by my line manager 
13.7 (17) 45.2 (56) 32.3 (40) 6.5 (8) 2.4 (3) 
Other pharmacists I know interpret and apply relevant research 
outcomes to their practice  
12.1 (15) 47.6 (59) 28.2 (35) 9.7 (12) 2.4 (3) 
Other health professionals I know interpret and apply relevant 
research outcomes to their practice 
19.4 (24) 58.9 (73) 17.7 (22) 3.2 (4) 0.8 (1) 
I already have access to all of the resources I need to interpret and 
apply relevant research outcomes to their practice 
4.0 (5) 16.9 (21) 37.1 (46) 33.9 (42) 8.1 (10) 
I have sufficient time to interpret and apply relevant research 
outcomes to their practice 
1.6 (2) 16.9 (21) 20.2 (25) 41.9 (52) 19.4 (24) 
Component statistics, sum of allocating 1 (strongly disagree) to 5 (strongly agree)  
Cronbach’s alpha 0.88 
Range possible 7-35, with 35 representing best positive attitudinal score 
Mid-point 21 
Median 23 
IQR 20-26 
 
